Home  »  Company   »  SELLAS Life Sciences Group Inc. (NASDAQ:SLS) Has S...

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) Has Seen A Fall Of -63.93% This Year, Is It Still A Better Option Than Others?

In last trading session, SELLAS Life Sciences Group Inc. (NASDAQ:SLS) saw 0.13 million shares changing hands with its beta currently measuring 2.26. Company’s recent per share price level of $2.46 trading at $0.04 or 1.65% at ring of the bell on the day assigns it a market valuation of $51.19M. That closing price of SLS’s stock is at a discount of -200.81% from its 52-week high price of $7.40 and is indicating a premium of 28.05% from its 52-week low price of $1.77. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.69 million shares which gives us an average trading volume of 350.44K if we extend that period to 3-months.

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) trade information

Upright in the green during last session for gaining 1.65%, in the last five days SLS remained trading in the green while hitting it’s week-highest on Friday, 11/18/22 when the stock touched $2.46 price level, adding 8.89% to its value on the day. SELLAS Life Sciences Group Inc.’s shares saw a change of -55.52% in year-to-date performance and have moved 0.41% in past 5-day. SELLAS Life Sciences Group Inc. (NASDAQ:SLS) showed a performance of -31.67% in past 30-days. Number of shares sold short was 0.82 million shares which calculate 8.62 days to cover the short interests.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Wall Street analysts have assigned a consensus price target of $8.00 to the stock, which implies a rise of 69.25% to its current value. Analysts have been projecting $4.00 as a low price target for the stock while placing it at a high target of $12.00. It follows that stock’s current price would drop -387.8% in reaching the projected high whereas dropping to the targeted low would mean a loss of -62.6% for stock’s current value.

SELLAS Life Sciences Group Inc. (SLS) estimates and forecasts

Statistics highlight that SELLAS Life Sciences Group Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -22.64% of value to its shares in past 6 months, showing an annual growth rate of -57.46% while that of industry is 4.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 13.30% in the current quarter and calculating 16.70% increase in the next quarter. This year revenue growth is estimated to fall -86.80% from the last financial year’s standing.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 73.00% during past 5 years.

SLS Dividends

SELLAS Life Sciences Group Inc. is more likely to be releasing its next quarterly report between November 10 and November 14 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

SELLAS Life Sciences Group Inc. (NASDAQ:SLS)’s Major holders

Insiders are in possession of 0.09% of company’s total shares while institution are holding 14.65 percent of that, with stock having share float percentage of 14.66%. Investors also watch the number of corporate investors in a company very closely, which is 14.65% institutions for SELLAS Life Sciences Group Inc. that are currently holding shares of the company. Empery Asset Management, LP is the top institutional holder at SLS for having 0.93 million shares of worth $2.07 million. And as of Jun 29, 2022, it was holding 4.52% of the company’s outstanding shares.

The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 0.83 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 4.04% of outstanding shares, having a total worth of $1.85 million.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 0.59 million shares of worth $1.32 million or 2.88% of the total outstanding shares. The later fund manager was in possession of 0.2 million shares on Jun 29, 2022, making its stake of worth around $0.45 million in the company or a holder of 0.98% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts